Comments on Proposed Rule Regarding Approach to PFAS Reporting Requirements and Supplier Notification for Chemicals of Special Concern Share page: Docket Number: EPA–HQ–TRI–2022–0270 Download Document Issues: OTC Medicines Dietary Supplements OTC Medical Devices Other Issues Packaging Sustainability PFAS Related Posts Effectiveness of Phenylephrine as an Oral Decongestant Letter Comments on the Background Document on Propylparaben and Butylparaben in Skin-Applied Leave-On Products Jan 16, 2025 Comments Comments Regarding Enhancing Coverage of Preventative Services Under the Affordable Care Act Dec 26, 2024
